Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
DMAC - DiaMedica Therapeutics Inc - Stock Price Chart
TickerDMAC [NASD]
CompanyDiaMedica Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap113.88MEPS (ttm)-0.62
P/E-EPS this Y-18.33%
Forward P/E-EPS next Y-16.90%
PEG-EPS past 5Y4.28%
P/S-EPS next 5Y30.00%
P/B2.23EPS Q/Q4.09%
Dividend-Sales Q/Q-
Insider Own37.35%Inst Own10.58%
Insider Trans0.14%Inst Trans-10.68%
Short Float0.74%EarningsMar 19/a
Analyst Recom1.00Target Price7.00
Avg Volume37.33K52W Range1.58 - 4.75
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wambeke David J.Chief Business OfficerNov 16 '23Buy2.4620,00049,200527,114Nov 16 04:37 PM
Von Koch Thomas10% OwnerJun 23 '23Buy3.401,470,5884,999,9994,326,435Jun 27 04:11 PM
Giuffre Randall MichaelDirectorJun 23 '23Buy3.9165,000254,150360,355Jun 26 04:42 PM
Wambeke David J.Chief Business OfficerJun 23 '23Buy3.9138,364150,003507,114Jun 26 04:14 PM
Pilnik Richard D.DirectorJun 23 '23Buy3.9138,363149,999248,245Jun 26 04:03 PM
HOUR - Hour Loop Inc - Stock Price Chart
TickerHOUR [NASD]
CompanyHour Loop Inc
CountryUSA
IndustryInternet Retail
Market Cap41.42MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-54.38%
P/S0.31EPS next 5Y-
P/B9.30EPS Q/Q38.74%
Dividend-Sales Q/Q16.14%
Insider Own95.12%Inst Own0.31%
Insider Trans0.00%Inst Trans-0.47%
Short Float1.61%EarningsMar 26/a
Analyst Recom3.00Target Price1.75
Avg Volume46.35K52W Range0.90 - 2.42
Apr-11-24 10:00AM CRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICA (PR Newswire) -5.46%
Mar-28-24 08:31AM Reborn Coffee Reports Fiscal Year 2023 Financial Results (GlobeNewswire) -8.13%
Mar-26-24 10:53PM HOUR Stock Earnings: Hour Loop Reported Results for Q4 2023 (InvestorPlace) -5.19%
04:05PM Hour Loop Reports Full Year 2023 Results (GlobeNewswire)
Nov-14-23 04:01PM Reborn Coffee Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-13-23 08:05AM Hour Loop Reports Third Quarter 2023 Results (GlobeNewswire) +5.02%
Oct-25-23 08:31AM Reborn Coffee and Hour Loop Expand Partnership on Amazon with Launch of Exclusive Organic Volcanic Tea (GlobeNewswire)
Aug-09-23 05:30PM Hour Loop Reports Second Quarter 2023 Results (GlobeNewswire)
May-12-23 08:05AM Hour Loop Reports First Quarter 2023 Results (GlobeNewswire)
Mar-31-23 04:05PM Hour Loop Reports Full Year 2022 Results (GlobeNewswire)
Hour Loop, Inc. is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market and sell products. It operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The company was founded by Sam Lai and Sau Kuen Yu in 2013 and is headquartered in Redmond, WA.
FAAS - DigiAsia Corp. - Stock Price Chart
TickerFAAS [NASD]
CompanyDigiAsia Corp.
CountrySingapore
IndustrySoftware - Infrastructure
Market Cap90.97MEPS (ttm)0.11
P/E78.36EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.67EPS Q/Q-112.90%
Dividend-Sales Q/Q-
Insider Own69.86%Inst Own13.75%
Insider Trans0.00%Inst Trans1.71%
Short Float0.80%Earnings-
Analyst Recom-Target Price-
Avg Volume78.44K52W Range4.76 - 13.99
DigiAsia Corp. operates as a financial technology frim. The company was founded by Alexander Steven Rusli on October 23, 2017 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Antony PrabhuPresident and CFOMar 12 '24Buy1725.00230396,750230Mar 12 09:17 PM
Marepally BhargavaChief Executive OfficerMar 12 '24Buy900.0011099,000110Mar 12 09:20 PM
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap84.58MEPS (ttm)-19.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y10.66%
P/S445.14EPS next 5Y-
P/B6.41EPS Q/Q82.28%
Dividend-Sales Q/Q-72.96%
Insider Own18.68%Inst Own12.65%
Insider Trans16.95%Inst Trans-41.48%
Short Float3.66%EarningsMay 15/a
Analyst Recom-Target Price-
Avg Volume27.73K52W Range2.80 - 13.63
authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Garchik Stephen Jeffrey10% OwnerApr 23 '24Buy6.8512,00082,2001,163,096Apr 25 08:00 AM
Garchik Stephen Jeffrey10% OwnerApr 12 '24Buy7.6910,50080,7451,151,096Apr 15 05:15 PM
Garchik Stephen Jeffrey10% OwnerJan 31 '24Buy9.405,70053,5801,140,596Feb 01 07:00 PM
Garchik Stephen Jeffrey10% OwnerJan 30 '24Buy9.102,50022,7501,134,896Jan 30 08:25 PM
Garchik Stephen Jeffrey10% OwnerJan 25 '24Buy9.401,0009,4001,132,396Jan 26 06:08 AM
BYND - Beyond Meat Inc - Stock Price Chart
TickerBYND [NASD, RUT]
CompanyBeyond Meat Inc
CountryUSA
IndustryPackaged Foods
Market Cap532.32MEPS (ttm)-5.25
P/E-EPS this Y54.66%
Forward P/E-EPS next Y20.45%
PEG-EPS past 5Y-60.31%
P/S1.55EPS next 5Y10.00%
P/B-EPS Q/Q-129.07%
Dividend-Sales Q/Q-7.83%
Insider Own5.07%Inst Own46.52%
Insider Trans0.00%Inst Trans-38.47%
Short Float37.30%EarningsMay 08/a
Analyst Recom3.87Target Price6.50
Avg Volume3.53M52W Range5.58 - 19.25
Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.
TDW - Tidewater Inc. - Stock Price Chart
TickerTDW [NYSE, RUT]
CompanyTidewater Inc.
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap5.57BEPS (ttm)2.51
P/E42.44EPS this Y184.98%
Forward P/E12.71EPS next Y60.01%
PEG8.49EPS past 5Y-
P/S4.89EPS next 5Y5.00%
P/B5.32EPS Q/Q318.94%
Dividend-Sales Q/Q66.32%
Insider Own8.06%Inst Own94.83%
Insider Trans-1.07%Inst Trans19.78%
Short Float10.83%EarningsMay 02/a
Analyst Recom1.29Target Price104.17
Avg Volume772.53K52W Range39.41 - 101.10
Tidewater, Inc. engages in the provision of offshore marine support and transportation services to the offshore energy industry. The firm offers the towing of, and anchor handling for, mobile offshore drilling units, transporting supplies and personnel necessary to sustain drilling, work over and production activities, offshore construction and seismic and subsea support, geotechnical survey for wind farm construction, and a variety of specialized services such as pipe and cable laying. It operates through the following geographical segments: Americas, Asia Pacific, Middle East, Europe and Mediterranean, and West Africa. The company was founded in 1955 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kneen QuintinDIRECTOR, PRESIDENT & CEOMar 22 '24Option Exercise11.46603,7566,919,440791,907Mar 25 07:00 PM
Rubio Samuel REVP, CFO & CAOMar 05 '24Sale81.3619,6411,597,99298,036Mar 07 06:57 PM
Darling David EEVP, COO & CHIEF HR OFFICERMar 05 '24Sale82.0817,8211,462,74885,959Mar 07 06:58 PM
Hudson Daniel A.EVP & GENERAL COUNSELMar 05 '24Sale82.008,000656,000104,312Mar 07 07:00 PM
ROBOTTI ROBERTDirectorSep 07 '23Buy67.321,486100,0333,235,657Sep 11 10:47 AM
GOVX - Geovax Labs Inc - Stock Price Chart
TickerGOVX [NASD]
CompanyGeovax Labs Inc
CountryUSA
IndustryBiotechnology
Market Cap3.72MEPS (ttm)-14.28
P/E-EPS this Y29.81%
Forward P/E-EPS next Y-
PEG-EPS past 5Y92.12%
P/S-EPS next 5Y-
P/B0.55EPS Q/Q-26.06%
Dividend-Sales Q/Q-
Insider Own1.69%Inst Own9.06%
Insider Trans82.72%Inst Trans-
Short Float0.28%EarningsFeb 29/a
Analyst Recom1.00Target Price90.00
Avg Volume39.97K52W Range1.38 - 11.54
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DODD DAVID APresident, CEOFeb 22 '24Buy2.278,20918,66318,661Feb 22 04:41 PM
DODD DAVID APresident, CEOFeb 21 '24Buy2.155201,11810,452Feb 22 04:41 PM
Reynolds MarkCFOFeb 07 '24Buy2.772,0005,5407,213Feb 07 04:43 PM
McKee Kelly T. Jr.Chief Medical OfficerDec 22 '23Buy0.366,9442,50035,782Dec 26 03:51 PM
McKee Kelly T. Jr.Chief Medical OfficerSep 25 '23Buy0.529,6535,02028,838Sep 27 04:33 PM
ACRV - Acrivon Therapeutics Inc - Stock Price Chart
TickerACRV [NASD, RUT]
CompanyAcrivon Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap296.14MEPS (ttm)-2.73
P/E-EPS this Y-1.79%
Forward P/E-EPS next Y1.10%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.78EPS Q/Q-101.64%
Dividend-Sales Q/Q-
Insider Own32.95%Inst Own62.15%
Insider Trans30.08%Inst Trans-
Short Float4.95%EarningsMar 28/b
Analyst Recom1.20Target Price21.22
Avg Volume783.66K52W Range3.19 - 14.30
Apr-29-24 07:08AM Ladenburg Thalmann Downgrades Acrivon Therapeutics to Neutral (MT Newswires) +18.20%
Apr-24-24 04:01PM Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progress Today at Corporate R&D Event (GlobeNewswire)
Apr-16-24 08:01PM Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316 (GlobeNewswire)
Apr-10-24 08:00AM Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368 (GlobeNewswire) +8.00%
Apr-09-24 10:32AM ACRV Stock Jumps 55% as Acrivon Therapeutics Gets $130 Million Boost (InvestorPlace) +62.77%
07:00AM Acrivon Therapeutics Announces $130 Million Private Placement Financing (GlobeNewswire)
Mar-30-24 05:31AM Acrivon Therapeutics Inc (ACRV) Reports Increased Annual Loss: A Detailed Look Against Analyst ... (GuruFocus.com)
Mar-28-24 12:52PM ACRV Stock Earnings: Acrivon Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +10.60%
08:00AM Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights (GlobeNewswire)
Mar-05-24 04:30PM Acrivon Therapeutics to Present Data at AACR Annual Meeting Demonstrating Power of Acrivon Predictive Precision Proteomics (AP3) Platform and its Internally-Discovered, Potent WEE1/PKMYT1 Development Candidate, ACR-2316 (GlobeNewswire)
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERCEPTIVE ADVISORS LLC10% OwnerApr 11 '24Buy8.502,353,00020,000,5005,360,858Apr 15 08:53 AM
Chione Ltd10% OwnerJun 26 '23Sale12.93162073,848,632Jun 28 03:47 PM
Holm-Jorgensen RasmusChief Financial OfficerJun 16 '23Option Exercise3.639,50034,48529,530Jun 20 05:21 PM
Chione Ltd10% OwnerJun 15 '23Sale12.142,05624,9603,848,648Jun 20 05:15 PM
Chione Ltd10% OwnerJun 14 '23Sale12.1389310,8323,850,704Jun 14 06:33 PM
AWIN - AERWINS Technologies Inc - Stock Price Chart
TickerAWIN [NASD]
CompanyAERWINS Technologies Inc
CountryUSA
IndustryScientific & Technical Instruments
Market Cap3.36MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-99.99%
Dividend-Sales Q/Q-
Insider Own32.61%Inst Own1.74%
Insider Trans0.00%Inst Trans-
Short Float1.62%Earnings-
Analyst Recom1.00Target Price100.00
Avg Volume118.36K52W Range2.12 - 76.00
AERWINS Technologies, Inc. engages in the development of technologies to enable air mobility. It has developed XTURISMO, a hoverbike, and the C.O.S.M.O.S. flight operation management system. It also offers drone-based solution services. The company was founded in 2017 and is headquartered in Middletown, DE.
SLQT - SelectQuote Inc - Stock Price Chart
TickerSLQT [NYSE, RUT]
CompanySelectQuote Inc
CountryUSA
IndustryInsurance Brokers
Market Cap344.74MEPS (ttm)-0.30
P/E-EPS this Y42.86%
Forward P/E-EPS next Y62.50%
PEG-EPS past 5Y-
P/S0.30EPS next 5Y-9.70%
P/B1.02EPS Q/Q-15.53%
Dividend-Sales Q/Q27.02%
Insider Own20.86%Inst Own34.97%
Insider Trans0.00%Inst Trans1.69%
Short Float0.43%EarningsFeb 07/b
Analyst Recom2.00Target Price4.00
Avg Volume738.53K52W Range0.95 - 2.39
SelectQuote, Inc. operates as a technology-enabled, direct-to-consumer distribution platform that provides consumers with a transparent and convenient venue to shop for complex senior health, life, and auto and home insurance policies from a curated panel of insurance carriers. The company operates through the following segments: Senior, Healthcare Services, Life, Auto and Home, and Corp and Elims. The company was founded on August 18, 1999 and is headquartered in Overland Park, KS.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Clement Ryan MooreChief Financial OfficerMar 01 '24Option Exercise0.006,234047,367Mar 01 07:50 PM
Clement Ryan MooreChief Financial OfficerFeb 28 '24Option Exercise0.0020,833041,133Mar 01 07:50 PM
GRANT W THOMAS IIDirectorNov 14 '23Option Exercise0.00203,12502,596,594Nov 16 07:44 PM
Weldon Raymond FDirectorNov 14 '23Option Exercise0.00203,1250365,693Nov 16 07:44 PM
Devine Denise LDirectorNov 14 '23Option Exercise0.00203,1250219,693Nov 16 07:43 PM
1234567891020